Search Results - "Sarzana, Marina"
-
1
-
2
P1392: INTERIM ANALYSIS OF FIRST IN HUMAN PHASE I‐II CLINICAL TRIAL OF EX‐VIVO GENE THERAPY FOR HURLER SYNDROME: AN UPDATE AT 3 YEAR FOLLOW‐UP
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
3
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded access
Published in The Lancet (British edition) (22-01-2022)“…Effective treatment for metachromatic leukodystrophy (MLD) remains a substantial unmet medical need. In this study we investigated the safety and efficacy of…”
Get full text
Journal Article -
4
Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome
Published in The New England journal of medicine (18-11-2021)“…Eight patients with Hurler syndrome who lacked suitable allogeneic donors received autologous hematopoietic stem and progenitor cells transduced ex vivo with…”
Get full text
Journal Article -
5
Lentiviral hematopoietic stem cell gene therapy (atidarsagene autotemcel) for late juvenile metachromatic leukodystrophy (MLD)
Published in Molecular genetics and metabolism (01-02-2024)Get full text
Journal Article -
6
Metachromatic leukodystrophy: A single‐center longitudinal study of 45 patients
Published in Journal of inherited metabolic disease (01-09-2021)“…In this study, we characterize the natural course of metachromatic leukodystrophy (MLD), explore intra/inter group differences, and identify biomarkers to…”
Get full text
Journal Article -
7
-
8
Early skeletal outcomes after hematopoietic stem and progenitor cell gene therapy for Hurler syndrome
Published in Science translational medicine (01-05-2024)“…Mucopolysaccharidosis type I Hurler (MPSIH) is characterized by severe and progressive skeletal dysplasia that is not fully addressed by allogeneic…”
Get more information
Journal Article -
9
-
10
-
11
The Italian Consensus Conference on the role of rehabilitation for children and adolescents with leukemia, central nervous system tumors, and bone cancer, part 2: general principles for the rehabilitation treatment of motor function impairments
Published in Pediatric hematology and oncology (01-08-2024)“…In Italy, 1400 children and 800 adolescents are diagnosed with cancer every year. About 80% of them can be cured but are at high risk of experiencing severe…”
Get full text
Journal Article -
12
-
13
Preserving Ambulation in a Gene Therapy-Treated Girl Affected by Metachromatic Leukodystrophy: A Case Report
Published in Journal of personalized medicine (01-04-2023)“…(1) Background: Atidarsagene autotemcel is a hematopoietic stem and progenitor cell gene therapy (HSPC-GT) approved to treat early-onset metachromatic…”
Get full text
Journal Article -
14
-
15
-
16
-
17